Improving Ovarian Reserve: rhLH Treatment Study

We are investigating whether a hormone treatment can increase the number of healthy follicles in women trying to conceive. This study aims to assess its effects on fertility and overall safety.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Luveris
Luveris is a fertility medicine used to help stimulate egg development and ovulation in women undergoing fertility treatments.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Lutropin Alfa
Lutropin alfa is a lab-made luteinizing hormone that helps trigger ovulation and support fertility treatments.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Azienda Ospedaliero Universitaria Di Modena
Ostetricia-Ginecologia
Modena, Italy
A.O.U. Città della Salute e dalla Scienza di Torino
Ginecologia e Ostetricia
Turin, Italy
San Raffaele Hospital
Centro Scienze Natalità
Vimodrone, Italy
Sponsor: Azienda Ospedaliero Universitaria Di Modena
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.